Tokyo Tape
Sign in
← Kirin Holdings

Quarterly report · Q1

2503.TEDINET S100TE18
Period2024-01-01 → 2024-03-31
Filed2024-05-13
StandardIFRS
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 47
MetricValuePeriodScopeSource row
Revenue¥501.8bn2024-01-01 → 2024-03-31Cons.Revenue IFRS
Revenue¥2.13T2023-01-01 → 2023-12-31Cons.Revenue IFRS (5-year summary)
Revenue¥450.3bn2023-01-01 → 2023-03-31Cons.Revenue IFRS
Operating income¥30.8bn2024-01-01 → 2024-03-31Cons.Operating profit loss IFRS
Operating income¥11.0bn2023-01-01 → 2023-03-31Cons.Operating profit loss IFRS
Profit before tax¥44.2bn2024-01-01 → 2024-03-31Cons.Profit loss before tax IFRS
Profit before tax¥197.0bn2023-01-01 → 2023-12-31Cons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥20.1bn2023-01-01 → 2023-03-31Cons.Profit loss before tax IFRS
Net income (owners)¥25.9bn2024-01-01 → 2024-03-31Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥112.7bn2023-01-01 → 2023-12-31Cons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥5.6bn2023-01-01 → 2023-03-31Cons.Profit loss attributable to owners of parent IFRS
Net income¥32.6bn2024-01-01 → 2024-03-31Cons.Profit loss IFRS
Net income¥11.3bn2023-01-01 → 2023-03-31Cons.Profit loss IFRS
Total assets¥3.00Tat 2024-03-31Cons.Assets IFRS
Total assets¥2.87Tat 2023-12-31Cons.Assets IFRS
Total assets¥2.47Tat 2023-03-31Cons.Total assets IFRS (5-year summary)
Total liabilities¥1.55Tat 2024-03-31Cons.Liabilities IFRS
Total liabilities¥1.44Tat 2023-12-31Cons.Liabilities IFRS
Net assets / equity¥1.46Tat 2024-03-31Cons.Equity IFRS
Net assets / equity¥1.43Tat 2023-12-31Cons.Equity IFRS
Net assets / equity¥1.23Tat 2023-03-31Cons.Equity IFRS
Net assets / equity¥1.25Tat 2022-12-31dCons.Equity IFRS
Equity (owners)¥1.16Tat 2024-03-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥1.13Tat 2023-12-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥971.9bnat 2023-03-31Cons.Equity attributable to owners of parent IFRS (5-year summary)
Cash & equivalents¥151.2bnat 2024-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥131.4bnat 2023-12-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥116.9bnat 2023-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥88.1bnat 2022-12-31dCons.Cash and cash equivalents IFRS
Operating cash flow¥39.9bn2024-01-01 → 2024-03-31Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥203.2bn2023-01-01 → 2023-12-31Cons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥41.9bn2023-01-01 → 2023-03-31Cons.Net cash provided by used in operating activities IFRS
Investing cash flow−¥65.3bn2024-01-01 → 2024-03-31Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥226.1bn2023-01-01 → 2023-12-31Cons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥31.4bn2023-01-01 → 2023-03-31Cons.Net cash provided by used in investing activities IFRS
Financing cash flow¥34.7bn2024-01-01 → 2024-03-31Cons.Net cash provided by used in financing activities IFRS
Financing cash flow¥35.9bn2023-01-01 → 2023-12-31Cons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow−¥8.6bn2023-01-01 → 2023-03-31Cons.Net cash provided by used in financing activities IFRS
EPS (basic)¥31.982024-01-01 → 2024-03-31Cons.Basic earnings loss per share IFRS
EPS (basic)¥139.162023-01-01 → 2023-12-31Cons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥6.92023-01-01 → 2023-03-31Cons.Basic earnings loss per share IFRS
EPS (diluted)¥31.982024-01-01 → 2024-03-31Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥139.152023-01-01 → 2023-12-31Cons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥6.92023-01-01 → 2023-03-31Cons.Diluted earnings loss per share IFRS
Equity ratio38.7%at 2024-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio39.5%at 2023-12-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio39.4%at 2023-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 46
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2024-01-01 → 2024-03-31¥20.0bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2024-01-01 → 2024-03-31¥4.6bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2024-01-01 → 2024-03-31¥15.3bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2024-01-01 → 2024-03-31−¥158m
Reconciling Itemsreconcilingrevenue2024-01-01 → 2024-03-31−¥17.2bn
Reconciling Itemsreconcilingrevenue intersegment2024-01-01 → 2024-03-31−¥17.2bn
Reconciling Itemsreconcilingsegment profit2024-01-01 → 2024-03-31−¥12.3bn
jpcrp040300-q1r_E00395-000Alcoholic Beveragesreportable segmentrevenue2024-01-01 → 2024-03-31¥238.6bn
jpcrp040300-q1r_E00395-000Alcoholic Beveragesreportable segmentrevenue external2024-01-01 → 2024-03-31¥238.2bn
jpcrp040300-q1r_E00395-000Alcoholic Beveragesreportable segmentrevenue intersegment2024-01-01 → 2024-03-31¥379m
jpcrp040300-q1r_E00395-000Alcoholic Beveragesreportable segmentsegment profit2024-01-01 → 2024-03-31¥18.4bn
jpcrp040300-q1r_E00395-000Health Sciencereportable segmentrevenue2024-01-01 → 2024-03-31¥32.7bn
jpcrp040300-q1r_E00395-000Health Sciencereportable segmentrevenue external2024-01-01 → 2024-03-31¥31.9bn
jpcrp040300-q1r_E00395-000Health Sciencereportable segmentrevenue intersegment2024-01-01 → 2024-03-31¥726m
jpcrp040300-q1r_E00395-000Health Sciencereportable segmentsegment profit2024-01-01 → 2024-03-31−¥1.7bn
jpcrp040300-q1r_E00395-000Non Alcoholic Beveragesreportable segmentrevenue2024-01-01 → 2024-03-31¥122.2bn
jpcrp040300-q1r_E00395-000Non Alcoholic Beveragesreportable segmentrevenue external2024-01-01 → 2024-03-31¥121.5bn
jpcrp040300-q1r_E00395-000Non Alcoholic Beveragesreportable segmentrevenue intersegment2024-01-01 → 2024-03-31¥645m
jpcrp040300-q1r_E00395-000Non Alcoholic Beveragesreportable segmentsegment profit2024-01-01 → 2024-03-31¥12.2bn
jpcrp040300-q1r_E00395-000Pharmaceuticalsreportable segmentrevenue2024-01-01 → 2024-03-31¥105.6bn
jpcrp040300-q1r_E00395-000Pharmaceuticalsreportable segmentrevenue external2024-01-01 → 2024-03-31¥105.5bn
jpcrp040300-q1r_E00395-000Pharmaceuticalsreportable segmentrevenue intersegment2024-01-01 → 2024-03-31¥67m
jpcrp040300-q1r_E00395-000Pharmaceuticalsreportable segmentsegment profit2024-01-01 → 2024-03-31¥16.5bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2023-01-01 → 2023-03-31¥22.3bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2023-01-01 → 2023-03-31¥6.4bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2023-01-01 → 2023-03-31¥16.0bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2023-01-01 → 2023-03-31−¥265m
Reconciling Itemsreconcilingrevenue2023-01-01 → 2023-03-31−¥18.0bn
Reconciling Itemsreconcilingrevenue intersegment2023-01-01 → 2023-03-31−¥18.0bn
Reconciling Itemsreconcilingsegment profit2023-01-01 → 2023-03-31−¥11.5bn
jpcrp040300-q1r_E00395-000Alcoholic Beveragesreportable segmentrevenue2023-01-01 → 2023-03-31¥225.4bn
jpcrp040300-q1r_E00395-000Alcoholic Beveragesreportable segmentrevenue external2023-01-01 → 2023-03-31¥225.1bn
jpcrp040300-q1r_E00395-000Alcoholic Beveragesreportable segmentrevenue intersegment2023-01-01 → 2023-03-31¥300m
jpcrp040300-q1r_E00395-000Alcoholic Beveragesreportable segmentsegment profit2023-01-01 → 2023-03-31¥20.9bn
jpcrp040300-q1r_E00395-000Health Sciencereportable segmentrevenue2023-01-01 → 2023-03-31¥18.4bn
jpcrp040300-q1r_E00395-000Health Sciencereportable segmentrevenue external2023-01-01 → 2023-03-31¥17.4bn
jpcrp040300-q1r_E00395-000Health Sciencereportable segmentrevenue intersegment2023-01-01 → 2023-03-31¥991m
jpcrp040300-q1r_E00395-000Health Sciencereportable segmentsegment profit2023-01-01 → 2023-03-31−¥1.4bn
jpcrp040300-q1r_E00395-000Non Alcoholic Beveragesreportable segmentrevenue2023-01-01 → 2023-03-31¥108.6bn
jpcrp040300-q1r_E00395-000Non Alcoholic Beveragesreportable segmentrevenue external2023-01-01 → 2023-03-31¥108.0bn
jpcrp040300-q1r_E00395-000Non Alcoholic Beveragesreportable segmentrevenue intersegment2023-01-01 → 2023-03-31¥609m
jpcrp040300-q1r_E00395-000Non Alcoholic Beveragesreportable segmentsegment profit2023-01-01 → 2023-03-31¥9.6bn
jpcrp040300-q1r_E00395-000Pharmaceuticalsreportable segmentrevenue2023-01-01 → 2023-03-31¥93.5bn
jpcrp040300-q1r_E00395-000Pharmaceuticalsreportable segmentrevenue external2023-01-01 → 2023-03-31¥93.4bn
jpcrp040300-q1r_E00395-000Pharmaceuticalsreportable segmentrevenue intersegment2023-01-01 → 2023-03-31¥107m
jpcrp040300-q1r_E00395-000Pharmaceuticalsreportable segmentsegment profit2023-01-01 → 2023-03-31¥16.2bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 779
ItemContextValueUnit
Changes in ownership interests in subsidiaries that do not result in loss of control ss IFRSCurrentYTDDuration_EffectivePortionOfCashFlowHedgesIFRSMember－JPY
Changes in ownership interests in subsidiaries that do not result in loss of control ss IFRSCurrentYTDDuration_OtherComponentsOfEquityIFRSMember－JPY
Changes in ownership interests in subsidiaries that do not result in loss of control ss IFRSCurrentYTDDuration_EquityAttributableToOwnersOfParentIFRSMember-2189000000JPY
Changes in ownership interests in subsidiaries that do not result in loss of control ss IFRSCurrentYTDDuration_NonControllingInterestsIFRSMember-5204000000JPY
Changes in ownership interests in subsidiaries that do not result in loss of control ss IFRSCurrentYTDDuration-7393000000JPY
Transfer from other components of equity to retained earnings ss IFRSCurrentYTDDuration_ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember－JPY
Transfer from other components of equity to retained earnings ss IFRSCurrentYTDDuration_EffectivePortionOfCashFlowHedgesIFRSMember－JPY
Transfer from other components of equity to retained earnings ss IFRSCurrentYTDDuration_OtherComponentsOfEquityIFRSMember354000000JPY
Transfer from other components of equity to retained earnings ss IFRSCurrentYTDDuration_EquityAttributableToOwnersOfParentIFRSMember－JPY
Transfer from other components of equity to retained earnings ss IFRSCurrentYTDDuration_NonControllingInterestsIFRSMember－JPY
Transfer from other components of equity to retained earnings ss IFRSCurrentYTDDuration－JPY
Total transactions with owners IFRSCurrentYTDDuration_ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember－JPY
Total transactions with owners IFRSCurrentYTDDuration_EffectivePortionOfCashFlowHedgesIFRSMember－JPY
Total transactions with owners IFRSCurrentYTDDuration_OtherComponentsOfEquityIFRSMember354000000JPY
Total transactions with owners IFRSCurrentYTDDuration_EquityAttributableToOwnersOfParentIFRSMember-31655000000JPY
Total transactions with owners IFRSCurrentYTDDuration_NonControllingInterestsIFRSMember-12447000000JPY
Total transactions with owners IFRSCurrentYTDDuration-44102000000JPY
Equity IFRSCurrentQuarterInstant_ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember148279000000JPY
Equity IFRSCurrentQuarterInstant_EffectivePortionOfCashFlowHedgesIFRSMember614000000JPY
Equity IFRSCurrentQuarterInstant_OtherComponentsOfEquityIFRSMember168599000000JPY
Equity IFRSCurrentQuarterInstant_EquityAttributableToOwnersOfParentIFRSMember1162553000000JPY
Equity IFRSCurrentQuarterInstant_NonControllingInterestsIFRSMember294906000000JPY
Equity IFRSCurrentQuarterInstant1457459000000JPY
Profit loss before tax IFRSPrior1YTDDuration20063000000JPY
Profit loss before tax IFRSCurrentYTDDuration44172000000JPY
Depreciation and amortization ope cf IFRSPrior1YTDDuration19860000000JPY
Depreciation and amortization ope cf IFRSCurrentYTDDuration21370000000JPY
Impairment losses reversal of impairment losses ope cf IFRSPrior1YTDDuration1315000000JPY
Impairment losses reversal of impairment losses ope cf IFRSCurrentYTDDuration503000000JPY
Interest and dividend income ope cf IFRSPrior1YTDDuration-819000000JPY
Interest and dividend income ope cf IFRSCurrentYTDDuration-3836000000JPY
Share of loss profit of investments accounted for using equity method ope cf IFRSPrior1YTDDuration-8485000000JPY
Share of loss profit of investments accounted for using equity method ope cf IFRSCurrentYTDDuration-9017000000JPY
Interest expenses ope cf IFRSPrior1YTDDuration1327000000JPY
Interest expenses ope cf IFRSCurrentYTDDuration2189000000JPY
Gain on sale of property plant and equipment and intangible assets ope cf IFRSPrior1YTDDuration-1155000000JPY
Gain on sale of property plant and equipment and intangible assets ope cf IFRSCurrentYTDDuration-2406000000JPY
Loss gain on sale and retirement of property plant and equipment and intangible assets ope cf IFRSPrior1YTDDuration195000000JPY
Loss gain on sale and retirement of property plant and equipment and intangible assets ope cf IFRSCurrentYTDDuration600000000JPY
Loss on sale of subsidiaries ope cf IFRSPrior1YTDDuration19358000000JPY
Loss on sale of subsidiaries ope cf IFRSCurrentYTDDuration－JPY
Decrease increase in trade receivables ope cf IFRSPrior1YTDDuration79681000000JPY
Decrease increase in trade receivables ope cf IFRSCurrentYTDDuration49753000000JPY
Decrease increase in inventories ope cf IFRSPrior1YTDDuration-15744000000JPY
Decrease increase in inventories ope cf IFRSCurrentYTDDuration-14531000000JPY
Increase decrease in trade payables ope cf IFRSPrior1YTDDuration-24875000000JPY
Increase decrease in trade payables ope cf IFRSCurrentYTDDuration-10692000000JPY
Increase decrease in liquor taxes payable ope cf IFRSPrior1YTDDuration-23280000000JPY
Increase decrease in liquor taxes payable ope cf IFRSCurrentYTDDuration-7288000000JPY
Increase decrease in deposits received ope cf IFRSPrior1YTDDuration-4813000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2023-12-31pass
balance sheet identityconsolidated 2024-03-31pass
dei present pass
period resolution pass
statement vs summary · net income attributable to parentconsolidated 2023-01-01/2023-03-31pass
statement vs summary · net income attributable to parentconsolidated 2024-01-01/2024-03-31pass
statement vs summary · operating cash flowconsolidated 2023-01-01/2023-03-31pass
statement vs summary · operating cash flowconsolidated 2024-01-01/2024-03-31pass
statement vs summary · revenueconsolidated 2023-01-01/2023-03-31pass
statement vs summary · revenueconsolidated 2024-01-01/2024-03-31pass
statement vs summary · total assetsconsolidated 2023-12-31pass
statement vs summary · total assetsconsolidated 2024-03-31pass